GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xbrane Biopharma AB (OSTO:XBRANE) » Definitions » E10

Xbrane Biopharma AB (OSTO:XBRANE) E10 : kr-1.47 (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Xbrane Biopharma AB E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Xbrane Biopharma AB's adjusted earnings per share data for the three months ended in Sep. 2024 was kr-0.030. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is kr-1.47 for the trailing ten years ended in Sep. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-12-14), Xbrane Biopharma AB's current stock price is kr0.1666. Xbrane Biopharma AB's E10 for the quarter that ended in Sep. 2024 was kr-1.47. Xbrane Biopharma AB's Shiller PE Ratio of today is .


Xbrane Biopharma AB E10 Historical Data

The historical data trend for Xbrane Biopharma AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xbrane Biopharma AB E10 Chart

Xbrane Biopharma AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Xbrane Biopharma AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -1.53 -1.51 -1.47

Competitive Comparison of Xbrane Biopharma AB's E10

For the Biotechnology subindustry, Xbrane Biopharma AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xbrane Biopharma AB's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Xbrane Biopharma AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Xbrane Biopharma AB's Shiller PE Ratio falls into.



Xbrane Biopharma AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Xbrane Biopharma AB's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.03/132.3043*132.3043
=-0.030

Current CPI (Sep. 2024) = 132.3043.

Xbrane Biopharma AB Quarterly Data

per share eps CPI Adj_EPS
201412 -0.064 100.225 -0.084
201503 -0.521 99.950 -0.690
201506 -0.643 99.995 -0.851
201509 -1.976 100.228 -2.608
201512 -0.257 100.276 -0.339
201603 -0.160 100.751 -0.210
201606 -0.175 101.019 -0.229
201609 -0.210 101.138 -0.275
201612 -0.197 102.022 -0.255
201703 -0.197 102.022 -0.255
201706 -0.170 102.752 -0.219
201709 -0.164 103.279 -0.210
201712 -0.362 103.793 -0.461
201803 -0.167 103.962 -0.213
201806 -0.582 104.875 -0.734
201809 0.943 105.679 1.181
201812 -0.563 105.912 -0.703
201903 -0.584 105.886 -0.730
201906 -0.638 106.742 -0.791
201909 -0.298 107.214 -0.368
201912 -0.497 107.766 -0.610
202003 -0.381 106.563 -0.473
202006 -0.353 107.498 -0.434
202009 -0.339 107.635 -0.417
202012 -0.339 108.296 -0.414
202103 -0.262 108.360 -0.320
202106 -0.303 108.928 -0.368
202109 -0.207 110.338 -0.248
202112 -0.139 112.486 -0.163
202203 -0.163 114.825 -0.188
202206 -0.153 118.384 -0.171
202209 -0.189 122.296 -0.204
202212 -0.261 126.365 -0.273
202303 -0.011 127.042 -0.011
202306 -0.017 129.407 -0.017
202309 -0.315 130.224 -0.320
202312 -0.610 131.912 -0.612
202403 -0.300 132.205 -0.300
202406 -0.050 132.716 -0.050
202409 -0.030 132.304 -0.030

Add all the adjusted EPS together and divide 10 will get our e10.


Xbrane Biopharma AB  (OSTO:XBRANE) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Xbrane Biopharma AB E10 Related Terms

Thank you for viewing the detailed overview of Xbrane Biopharma AB's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Xbrane Biopharma AB Business Description

Traded in Other Exchanges
Address
Retzius vag 8, Solna, SWE, 171 65
Xbrane Biopharma AB is a biotechnology company that develops biosimilars. The company follows drugs on already approved biological drugs that can be introduced at a lower price after the patent expires on the original drug. The company has a patented protein production platform with greater productivity than standard systems for producing proteins in E.coli host cells. Xbrane's product candidate is Ximluci, a ranibizumab biosimilar (original drug Lucentis) used in the treatment of various eye diseases, mainly the wet form of age-related macular degeneration.

Xbrane Biopharma AB Headlines

No Headlines